Document is current
Any future updates will be listed below
-
Authors
Honda, Hiroto https://orcid.org/0000-0003-3638-6358
Hashimoto, Naoko
Zenibayashi, Masako
Takeda, Akihiko
Takeuchi, Takehito
Yamamoto, Akane
Hirota, Yushi
-
Funding
Funding for this research was provided by:
Japan Association for Diabetes Education and Care (2017)
- License Information
-
More Information
Article History
Received: 7 May 2024
Accepted: 10 September 2024
First Online: 4 October 2024
Declarations
:
: YH has received lecture fees from Eli Lilly Japan K.K., Sanofi, Terumo Corp., Sumitomo Pharma Co. Ltd., and Abbott Japan LLC, as well as research support from Sumitomo Pharma Co. Ltd., Kyowa Kirin Co. Ltd., and Medtronic Japan Co. Ltd. The funders had no role in the study design; collection, analyses, or interpretation of data; writing of the manuscript; or decision to publish the results. The other authors declare no conflicts of interest.
: All the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (Aino University; date of approval: 3 April 2018; approval number: 2017-017) and with the Helsinki Declaration of 1964 and later versions. Informed consent was obtained from all the participants for being included in the study.
